RXDX
Prometheus Biosciences Inc
Price:  
199.92 
USD
Volume:  
1,860,050.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Prometheus EV/EBITDA

-118.3%
Upside

As of 2025-04-18, the EV/EBITDA ratio of Prometheus Biosciences Inc (RXDX) is -58.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Prometheus's latest enterprise value is 9,445.47 mil USD. Prometheus's TTM EBITDA according to its financial statements is -161.61 mil USD. Dividing these 2 quantities gives us the above Prometheus EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.8x - 9.8x 8.8x
Forward P/E multiples 8.7x - 19.7x 14.2x
Fair Price (27.04) - (30.75) (36.50)
Upside -113.5% - -115.4% -118.3%
199.92 USD
Stock Price
(36.50) USD
Fair Price

Prometheus EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA